Mcintyre Freedman & Flynn Investment Advisers Inc
Source: SEC Form 13F · as of Mar 2026Mcintyre Freedman & Flynn Investment Advisers Inc holds 10 biotech & pharma companies tracked by BioSniper, totaling $13.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$13.0M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 26,795 | $4.1M |
| MRKMerck & Co., Inc. | 30,004 | $3.6M |
| JNJJOHNSON & JOHNSON | 11,970 | $2.9M |
| AMGNAMGEN INC | 1,574 | $554K |
| BMYBRISTOL MYERS SQUIBB CO | 8,000 | $485K |
| REGNREGENERON PHARMACEUTICALS, INC. | 426 | $329K |
| GILDGILEAD SCIENCES, INC. | 2,158 | $301K |
| LLYELI LILLY & Co | 282 | $259K |
| ABTABBOTT LABORATORIES | 2,140 | $220K |
| AZNASTRAZENECA PLC | 1,108 | $219K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.